CLSA Gives UltraTech Cement Top 'Outperform' Rating, But Costs Loom

INDUSTRIAL-GOODSSERVICES
Whalesbook Logo
AuthorKavya Nair|Published at:
CLSA Gives UltraTech Cement Top 'Outperform' Rating, But Costs Loom
Overview

CLSA started coverage of UltraTech Cement with a strong 'Outperform' rating and a ₹13,800 target price, pointing to solid Q4 FY26 results boosted by higher volumes and better operations. While UltraTech Cement is expanding aggressively and shows strong basics, it faces challenges. Rising input costs, driven by Middle East tensions, could squeeze profit margins in the short term. Analysts are mostly positive, but high valuations and competition need watching.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

CLSA has initiated coverage on UltraTech Cement with a strong 'Outperform' rating and a ₹13,800 target price. This bullish stance highlights the company's strengths, but also comes amid a complex mix of operational performance, ambitious expansion plans, and growing cost pressures.

Strong Q4 Performance

UltraTech Cement finished the fiscal year strongly, exceeding expectations with its fourth-quarter results. Net profit for Q4 FY26 increased 20.2% from the previous year to ₹2,983 crore, while revenue grew 12% to ₹25,799 crore. Earnings before interest, taxes, depreciation, and amortization (EBITDA) jumped 21.3% to ₹5,600 crore, and the EBITDA margin improved to 21.7% from 20% a year ago. This was fueled by 9% domestic volume growth, which outpaced the broader industry and solidified UltraTech's market leadership. Despite these strong figures, UltraTech Cement's shares saw a slight dip, trading near ₹11,880. This suggests the market is already considering potential short-term challenges alongside the positive outlook.

Analyst Views and Expansion

CLSA's ₹13,800 target price suggests about a 15% potential increase for UltraTech Cement shares. This is in line with other analysts who generally rate the stock a 'Buy,' with average 12-month targets ranging from ₹13,636 to ₹14,303. For example, Nomura reiterated a 'Buy' rating with a ₹13,900 target, citing better EBITDA due to improved pricing. Goldman Sachs also holds a 'Buy' rating, setting a ₹13,230 target, though it noted possible near-term margin impacts from higher energy costs. UltraTech Cement is pursuing aggressive expansion, planning to invest ₹10,000 crore annually to grow its grey cement capacity beyond 200 million tonnes per annum (MTPA). The company also announced a special dividend of ₹240 per share for FY26, reflecting strong cash generation.

Cost Pressures and Competition

However, competition is heating up. UltraTech Cement trades at a higher price-to-earnings (P/E) ratio than many peers. Its trailing twelve-month (TTM) P/E is around 46-50x, compared to Ambuja Cement (21-30x), ACC (9-10x), Shree Cement (50-72x), and Dalmia Bharat (30-49x). Adani Cement, comprising ACC and Ambuja, now holds over 16.6% of the market share, increasing competitive pressure. While India's infrastructure spending and housing demand are strong sector drivers, the industry as a whole faces rising input costs.

A key risk comes from Middle East geopolitical tensions, which analysts believe could increase production costs by ₹150 to ₹200 per tonne. This is due to rising prices for imported petcoke, coal, and packaging materials, with packaging costs alone possibly increasing by ₹50-60 per tonne. Such cost pressures could reduce EBITDA margins by an estimated 1.5-2% across the sector, even with price increases. UltraTech Cement has raised its prices, but passing the full cost increase onto a market with excess capacity remains difficult. This comes as cement prices recently hit a one-year high of ₹300-305 per 50 kg bag in April 2026. The company's debt-to-equity ratio of about 0.33-0.34 is manageable, but needs monitoring alongside its large capital spending plans. The company's higher valuation could be challenged if cost pressures lead to lower margins or if expected volume growth slows due to economic weakness or tougher competition. A wider market downturn or prolonged geopolitical crisis could also strain the company financially, despite its current strong outlook.

Future Outlook

Even with these cost pressures, UltraTech Cement remains optimistic. The company forecasts double-digit volume growth and targets mid-to-high teens EBITDA growth over the medium term. Analysts predict its return on equity (ROE) will climb from 11.3% in FY26 to 17.0% by FY29. Revenue is expected to reach ₹1,01,160 crore in FY27 and ₹1,21,282 crore by FY29, with earnings per share (EPS) also projected to grow significantly. The company's capacity to produce strong cash flows while managing major capital investments and maintaining its dividend is a core part of its investment appeal. However, UltraTech's future success will depend on how well it navigates rising input costs and keeps its market leadership in a more competitive and challenging environment. Some analysts see a potential 19.10% upside from current share prices, with a consensus target of ₹14,303, signaling ongoing confidence. Still, investors should closely watch cost trends and competitive reactions.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.